Sign In
Buy AGEN
$7.00
+0.0400 (+0.575%)
At Close: Aug 10, 2026
Agenus (AGEN) Q1 Earnings and Revenues Miss Estimates
09:06pm, Monday, 11'th May 2026
Agenus (AGEN) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $2.1 per share. This compares to a loss of $1.03 per share a year ago.
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #BATTMAN--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today reported financial results for the first quarter ended March 31, 2026, a
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
10:41am, Wednesday, 06'th May 2026
Here is how Agenus (AGEN) and Align Technology (ALGN) have performed compared to their sector so far this year.
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
04:30pm, Monday, 04'th May 2026
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #AGEN--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will release its first quarter 2026 financia
Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
11:00am, Monday, 04'th May 2026
Agenus (AGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock?
11:07am, Wednesday, 29'th Apr 2026
TECH gears up for Q3 results with modest revenue growth expected as biotech funding trends and product momentum shape the outlook.
Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect
01:36pm, Tuesday, 28'th Apr 2026
VRTX heads into Q1 earnings with Trikafta demand, rising Alyftrek sales, and Casgevy and Journavx sales in focus ahead of the May 4 report.
Here's How Henry Schein Is Placed Ahead of Q1 Earnings
09:31am, Tuesday, 28'th Apr 2026
HSIC heads into Q1 earnings results with steady estimates, a 5.1% revenue growth outlook and strength across distribution, specialty products and tech.
Will Lower Premiums Affect Cigna's Q1 Earnings? Key Insights Here
12:26pm, Monday, 27'th Apr 2026
CI approaches Q1 results with strong pharmacy growth but a steep premium drop, as estimates point to mixed year-over-year performance.
Here's Why Agenus (AGEN) is a Strong Momentum Stock
10:52am, Thursday, 23'rd Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026
10:00am, Tuesday, 21'st Apr 2026
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #AI--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that four abstracts highlighting botensilimab (BOT), alone or in co
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
08:00am, Tuesday, 21'st Apr 2026
LEXINGTON, Mass. & MARLOW, England--(BUSINESS WIRE)---- $AGEN #AAC--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and BAP Pharma, a global medicines access and clinical trial sup
Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?
10:42am, Monday, 20'th Apr 2026
Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #AACR2026--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memoria
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
01:01pm, Tuesday, 14'th Apr 2026
Does Agenus (AGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
